Vaxcyte Inc (NAS:PCVX)
$ 102.7 -1.37 (-1.32%) Market Cap: 12.80 Bil Enterprise Value: 10.82 Bil PE Ratio: 0 PB Ratio: 3.79 GF Score: 40/100

Q4 2023 Vaxcyte Inc Earnings Call Transcript

Feb 27, 2024 / 09:30PM GMT
Release Date Price: $81.05 (+2.63%)
Operator

Good afternoon, everyone. My name is Bo, and I will be your conference operator today. At this time, I would like to welcome everyone to the Vaxcyte fourth-quarter and full-year 2023 financial results conference call. (Operator Instructions) And just a reminder, today's call is being recorded.

Now at this time, I'll turn things over to Mr. Andrew Guggenheim, President and Chief Financial Officer of Vaxcyte. Please go ahead, sir.

Andrew Guggenhime
Vaxcyte Inc - Chief Financial Officer, Senior Vice President

Thank you, operator, and good afternoon, everyone. I'd like to welcome you to Vaxcyte's earnings conference call to discuss our 2023 results and to provide a business update. I'm joined today by our Chief Executive Officer, Grant Pickering, and our Executive Vice President and Chief Operating Officer, Jim Wassil.

Earlier this afternoon, we issued a news release announcing our results. Copies of this and our other news releases for the corporate presentation and SEC filings can be found in the Investors and Media section of our website.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot